Algorithm that predicts Covid-19 complications gets EUA
The FDA granted an emergency use authorization to an algorithm developed by Dascena to predict which Covid-19 patients might face unstable blood pressure or respiratory decline.
The FDA granted an emergency use authorization to an algorithm developed by Dascena to predict which Covid-19 patients might face unstable blood pressure or respiratory decline.
A round-up of funding announcements this week. Other companies that have raised new venture capital funding rounds this week include Genespire, HeartVista and Particle Health and Vida.